130 related articles for article (PubMed ID: 1565905)
1. Update of EORTC clinical trials in prostate cancer. The EORTC Genito-Urinary Group.
Newling DW; Pavone Macaluse M; Smith P; de Voogt HJ; Robinson MR; Schroder FH; Denis L; Jones WG; de Pauw M; Sylvester R
Semin Urol; 1992 Feb; 10(1):65-71. PubMed ID: 1565905
[No Abstract] [Full Text] [Related]
2. Complete androgen blockade for the treatment of prostate cancer.
Labrie F; Dupont A; Belanger A
Important Adv Oncol; 1985; ():193-217. PubMed ID: 3916740
[No Abstract] [Full Text] [Related]
3. Combined castration and androgen blockade therapy in prostate cancer. Conclusions.
Denis L; Mettlin C
Cancer; 1990 Sep; 66(5 Suppl):1086-9. PubMed ID: 2203520
[No Abstract] [Full Text] [Related]
4. Chemotherapy of advanced cancer of the prostate.
Wirth MP
Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
[No Abstract] [Full Text] [Related]
5. Adjuvant endocrine therapy after radical prostatectomy for stage D1 prostate carcinoma.
Stein A; deKernion JB
Semin Urol; 1990 Aug; 8(3):184-9. PubMed ID: 2119049
[No Abstract] [Full Text] [Related]
6. Combined androgen blockade: an update.
Klotz L
Urol Clin North Am; 2006 May; 33(2):161-6, v-vi. PubMed ID: 16631454
[TBL] [Abstract][Full Text] [Related]
7. [What is safe in the therapy of advanced prostatic cancer?].
Gropp C; Burk K
Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
[No Abstract] [Full Text] [Related]
8. [Review of phase III clinical trials on combined anti-androgen therapies in patients with metastasized prostatic cancer].
Denis L; Dalesio O; Murphy G
Prog Urol; 1993 Feb; 3(1):75-85. PubMed ID: 8485599
[No Abstract] [Full Text] [Related]
9. Prostatic cancer--what to do? Staging and prognostic factors in the primary therapy decision.
Faul P
Eur Urol; 1992; 22(2):89-98. PubMed ID: 1478236
[No Abstract] [Full Text] [Related]
10. [Clinical protocols in treatment of prostatic carcinoma in Europe. The role of EORTC and other organizations].
Newling DW
Urologe A; 1995 Sep; 34(5):374-81. PubMed ID: 7483153
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of advanced prostate cancer].
Leisinger HJ; Jichlinski P
Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
[No Abstract] [Full Text] [Related]
12. Treating advanced prostate cancer.
Health News; 1998 Nov; 4(14):7. PubMed ID: 9825716
[No Abstract] [Full Text] [Related]
13. [Cancer of the prostate. What treatment, for which patient, in 1986?].
Boccon-Gibod L
Ann Urol (Paris); 1986; 20(2):79-81. PubMed ID: 3717903
[No Abstract] [Full Text] [Related]
14. Prostate cancer--treatment of disseminated disease.
Abi-Aad AS; Opsomer RJ
Acta Urol Belg; 1996 May; 64(2):67-76. PubMed ID: 8701817
[No Abstract] [Full Text] [Related]
15. The final analysis of the EORTC Genito-Urinary Tract Cancer Co-Operative Group phase III clinical trial (protocol 30805) comparing orchidectomy, orchidectomy plus cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
Robinson MR; Smith PH; Richards B; Newling DW; de Pauw M; Sylvester R
Eur Urol; 1995; 28(4):273-83. PubMed ID: 8575493
[TBL] [Abstract][Full Text] [Related]
16. Total androgen suppression: are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma.
Foote JE; Crawford ED
Semin Urol; 1988 Nov; 6(4):291-302. PubMed ID: 3068767
[No Abstract] [Full Text] [Related]
17. The treatment of hormone refractory prostate cancer.
Panvichian R; Pienta KJ
Compr Ther; 1996 Feb; 22(2):81-7. PubMed ID: 8689867
[No Abstract] [Full Text] [Related]
18. Anemia in patients on combined androgen block therapy for prostate cancer.
Qian LX; Hua LX; Wu HF; Sui YG; Cheng SG; Zhang W; Li J; Wang XR
Asian J Androl; 2004 Dec; 6(4):383-4. PubMed ID: 15546035
[TBL] [Abstract][Full Text] [Related]
19. A critical review of the concept of total androgen ablation in the treatment of prostate cancer.
Schulze H; Isaacs JT; Coffey DS
Prog Clin Biol Res; 1987; 243A():1-19. PubMed ID: 3309968
[No Abstract] [Full Text] [Related]
20. Apples and oranges. Re: 7.4-year update of the ongoing bicalutamide Early Prostate Cancer (EPC) trial programme.
Sternberg CN
BJU Int; 2006 Mar; 97(3):435-8. PubMed ID: 16469001
[No Abstract] [Full Text] [Related]
[Next] [New Search]
